Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

121.47 +4.03 (+3.43%)
Streaming Delayed Price Updated: 12:23 PM EDT, Jul 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,745,120
Open 120.03
Bid (Size) 121.40 (4)
Ask (Size) 121.55 (2)
Prev. Close 117.44
Today's Range 119.39 - 123.69
52wk Range 62.55 - 170.47
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time
Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human transmission are low. 
Via Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
Investors might want to consider the top pharma stocks in the current environment as they are beating most others. 
Via InvestorPlace

Performance

YTD
+7.97%
+7.97%
1 Month
-18.25%
-18.25%
3 Month
+13.38%
+13.38%
6 Month
+10.97%
+10.97%
1 Year
-0.54%
-0.54%

More News

Read More
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
Via ACCESSWIRE
Moderna To Collaborate With Mitsubishi On Respiratory Vaccine Promotion In Japan
Via Benzinga
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
Via ACCESSWIRE
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
3 Biotech Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
Via InvestorPlace
What's Going On With Moderna Stock Friday?
Via Benzinga
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Going On With Moderna Stock Wednesday
Via Benzinga
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
Via Benzinga
Exposures COVID-19
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Via MarketBeat
Topics ETFs
Exposures COVID-19
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
Via Benzinga
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
Via ACCESSWIRE
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
Via Benzinga
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.